Dr. Erica Schwartz Confirmed as CDC Director Amidst Deep-Seated Challenges and Public Health Turmoil
admin Dr. Erica Schwartz has been confirmed as the next director of the Centers for Disease...
admin
Gold Ribbon Heroes: Jaylen & Ayla
The narrative of childhood cancer is frequently defined by clinical statistics and grueling treatment protocols,...
Paving the Path to a Cancer-Free Future: The Enduring Impact of Legacy Giving to the Cancer Research Institute
Including the Cancer Research Institute (CRI) in your will is a personal and meaningful way...
Tarsus Pharmaceuticals Acquires Alkeus Pharmaceuticals in Up to $800 Million Deal, Advancing Stargardt Disease Treatment
Tarsus Pharmaceuticals, a prominent developer of treatments across ophthalmology, dermatology, and infectious diseases, has announced...
Legacy of Hope How a Childhood Friendship and a Battle with Pediatric Cancer Fuel a 25-Mile Journey for CureSearch
The intersection of personal tragedy and philanthropic endurance will culminate this August on the rugged...
July: A Critical Call for UV Radiation Safety and Advances in Skin Cancer Immunotherapy
As July unfolds, marking Ultraviolet (UV) Radiation Safety Awareness Month, a renewed focus is cast...
FDA Grants Accelerated Approval to Replimune’s Tudriqev for Advanced Melanoma After Contentious Review Process
The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to Replimune’s novel...
The Evolving Landscape of Sarcoma Treatment: Immunotherapy Offers New Hope Amidst Complexity
Sarcoma, a rare and notably complex group of cancers, presents unique challenges for diagnosis and...
FDA Approves Orzeyful, a Groundbreaking Orexin-2 Agonist, Ushering in a New Era for Narcolepsy Type 1 Treatment
The U.S. Food and Drug Administration (FDA) has granted approval to Orzeyful, a novel medicine...
CureSearch Awards $2M for Neuroblastoma CAR T-Cell Therapy Trial
CureSearch for Children’s Cancer, a leading global nonprofit dedicated to accelerating the development of new...
